Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 8, 2024
Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort Study
Amrit Kaur Virdee, Fredrikke Christie Knudtzen, Josep M Llibre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2023
Risk of Depression in People With Human Immunodeficiency Virus: A Nationwide Population-based Matched Cohort Study
Cecilie V Vollmond, Malte M Tetens, Fie W Paulsen, et al.
Infectious Diseases (London, England)
|
October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men
Andrew D Redd, Marie Helleberg, Matthew Sievers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2023
Incidence of Childbirth, Pregnancy, Spontaneous Abortion, and Induced Abortion Among Women With Human Immunodeficiency Virus in a Nationwide Matched Cohort Study
Fie W Paulsen, Malte M Tetens, Cecilie V Vollmond, et al.
AIDS (London, England)
|
November 26, 2024
Use of nonbarrier contraceptives among women with HIV
Fie W Paulsen, Malte M Tetens, Jan Gerstoft, et al.
BMC Infectious Diseases
|
September 3, 2025
No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial)
Karen Brorup Heje, Magnus Søltoft Lindhardt, Alessandra Meddis, et al.
The Lancet. HIV
|
July 1, 2021
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 10, 2008
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
Damon P Eisen, Melinda M Dean, Marja A Boermeester, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 8, 2024
Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort Study
Amrit Kaur Virdee, Fredrikke Christie Knudtzen, Josep M Llibre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2023
Risk of Depression in People With Human Immunodeficiency Virus: A Nationwide Population-based Matched Cohort Study
Cecilie V Vollmond, Malte M Tetens, Fie W Paulsen, et al.
Infectious Diseases (London, England)
|
October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men
Andrew D Redd, Marie Helleberg, Matthew Sievers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2023
Incidence of Childbirth, Pregnancy, Spontaneous Abortion, and Induced Abortion Among Women With Human Immunodeficiency Virus in a Nationwide Matched Cohort Study
Fie W Paulsen, Malte M Tetens, Cecilie V Vollmond, et al.
AIDS (London, England)
|
November 26, 2024
Use of nonbarrier contraceptives among women with HIV
Fie W Paulsen, Malte M Tetens, Jan Gerstoft, et al.
BMC Infectious Diseases
|
September 3, 2025
No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial)
Karen Brorup Heje, Magnus Søltoft Lindhardt, Alessandra Meddis, et al.
The Lancet. HIV
|
July 1, 2021
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 10, 2008
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
Damon P Eisen, Melinda M Dean, Marja A Boermeester, et al.
Page
of 15